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1. Introduction 
Today cancer is one of the most important causes of death. Therefore, researches pertinent 
to diagnosis, prognosis and treatment of cancer increase day by day. A large part of cancer 
can be treated by surgery, radiotherapy and chemotherapy. Various compounds are used 
for chemotherapy. Most of these anti-cancer compounds are synthetics that have toxic 
adverse effects. Therefore, it is crucial to reveal beneficial effects of natural compounds such 
as milder side effects on normal cells and potential anti-tumour effects. A great number of 
these compounds also have the potential to be anti-cancerogenic. Thus, importance of 
natural food-derived anti-cancer compound consumption has recently increased. Researches 
demonstrate these anti-cancerogenic features through various mechanisms. These 
mechanisms also include inhibition of telomerase activity and induction of apoptosis. It is 
presumed that these mechanisms are in interaction with each other. After giving brief 
information on telomeres, telomerase activity and apoptosis in this chapter, we will address 
the effects of several compounds on telomerase activity and apoptosis and the possible 
relationship they have with each other. 
Telomeres, which are located at both termini of the chromosomes of eukaryotic organisms, 
contain DNA and protein. Telomeres are different from other chromosomal DNA sequences 
in terms of both structural and functional aspects. In vertebrates, telomere is shaped by 
tandem repetitions of a short pattern which consists of TTAGGG hexanucleotide. The 
lengths of these repetitions in kilo base vary from one organism to another. The telomeric 
DNA strand, which is rich in guanine, ends with a single stranded 3’overhang. This single-
stranded overhang folds onto the double-stranded telomere and forms the structure called t-
loop. Through formation of this t-loop, the capping structure formed at the ends of 
chromosomes protects the ends from end-to-end fusion, degradation and recombination. 
Telomere can preserve a certain length or gain or lose length through special proteins and 
telomerase enzyme. It was demonstrated that these special proteins fulfil certain duties by 
binding to single and double stranded telomere DNA. Telomeric repeat binding factor 1 
(TRF1) and telomeric repeat binding factor 2 (TRF2) are double-strand telomere DNA 
binding proteins. These proteins and some other proteins related to them are responsible for 
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formation of the telomere complex and t-loop. The telomere is protected through the 
complex formed by these proteins (Blackburn, 2000; Blackburn, 2001; Celli et al., 2005; Chan 
& Blackburn, 2002; De Lange, 2002; Griffith et al., 1999; Moyzis et al, 1988;Sfeir et al, 2009; 
Smogorzewska et al., 2000; van Steensel et al., 1998; van Steensel & de Lange, 1997). The 
other telomere proteins which compose this complex and their duties are summarized 
shortly in Table 1.  
 
Proteins Functions References 
Rap 1 
(Repressor activator protein 1) 
Mammalian Rap1, whose function is 
still unclear, TRF2-binding protein, 
negative regulator of telomere length.
Li & de Lange (2003); Li et 
al.  (2000); Bae & Baumann 
(2007); O’Connor et al. 
(2004); Sarthy et al. (2009); 
Sfeir et al. (2010); Martinez 
et al. (2010); Diotti & Loayza 
(2011); Palm & de Lange 
(2008); de Lange  (2009); 
Martínez & Blasco (2010).  
TIN2 
(TRF1 Interacting Nuclear protein 2)
TRF1-TRF2 binding protein, negative 
regulator of telomere length. 
Kim et al. (2004); Ye et al.  
(2004a); Diotti & Loayza 
(2011); Palm & de Lange 
(2008); de Lange (2009); 
Martínez & Blasco (2010).  
TPP1 
(previously called TINT1 
[Houghtaling et al. 2004], 
PTOP [Liu et al. 2004], and 
PIP1 [Ye et al. 2004b]) 
Plays a role in telomere capping by 
interacting with TIN2 and POT1. 
 
Liu et al. (2004); Ye et al. 
(2004b); Houghtaling et al. 
(2004); Diotti &Loayza 
(2011); Palm &de Lange 
(2008); de Lange (2009); 
Martínez &Blasco (2010); 
Zong et al. (2012); Takai et al. 
(2011); Wang & Lei (2011). 
POT 1 
(Protection of telomeres 1) 
Binds single-stranded TTAGGG 
repeats, necessary for telomere-length 
maintenance and telomere protection.
Baumann & Cech (2001); 
Loayza & de Lange (2003); 
Diotti & Loayza (2011); 
Palm & de Lange (2008); de 
Lange (2009); Martínez & 
Blasco (2010). 
TANK1 and TANK2 
Tankyrase (TANK) telomere-
associated poly (ADP-ribose) 
polymerase (PARP)  1 
Positive regulator of telomere length 
through inhibition of TRF1 
 
Smith et al. (1998); 
Kaminker et al. (2001). 
PINX1 
(PIN2-interacting protein X1) 
Potential telomerase inhibitor, 
negatively regulating telomere length 
by interacting with TRF1. 
Zhou & Lu (2001). 
Ku86 
Negative regulator of telomere length, 
role in telomere capping, regulation of 
telomerase recruitment. 
Espejel et al. (2002); 
Pfingsten et al. (2012). 
DNA-PK 
(DNA-dependent protein kinase) 
Plays a role in telomere capping, 
putative role in post-replicative 
processing of telomeres. 
Bailey et al. (2001). 
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Proteins Functions References 
ERCC1/XPF 
(excision repair cross-
complementing 1/ xeroderma 
pigmentosum group F) 
Negative mediator of telomere length 
maintenance.  
Zhu et al. (2003); Wu et al. 
(2008).   
Mre11/Rad50/Nbs1 
 
Binds TRF2, DNA-repair complex, 
possible role in T-loop formation. 
Zhu et al. (2000). 
PARP-2 
(poly (ADP-ribose) polymerase-2)
PARP activity negatively regulates 
TRF2. 
Dantzer et al. (2004). 
Apollo 
(also called SNM1B) 
TRF2 interacting, protein absence 
leads to DNA damage signal at 
telomeres. 
 
Lenain et al. (2006); 
van Overbeek & de Lange 
(2006); Wu et al. (2012). 
Table 1. Telomere-binding proteins and their functions 
Telomerase, which is a DNA polymerase with special ribonucleoprotein structure, is 
responsible for synthesis of DNA tandem repeats at chromosomal termini. This enzyme is 
active in embryonic cells and adult stem cells while inactive or at low level in normal 
somatic cells. Telomerase, which is a reverse transcriptase, consists of a catalytic subunit 
(hTERT=Human Telomerase Reverse Transcriptase) and an RNA component 
(hTR=hTERC=Human Telomerase RNA Complex). Human telomerase enzyme uses a short 
segment (8-30 bases) of hTR that is complementary to telomeric DNA sequence as the 
template for extension of 3’ strand of DNA sequence. In this way, telomerase enzyme 
increases the telomere length and prevents DNA loss known as the end replication problem 
that occurs at each cell division. When telomere length reaches the critical shortness, the cell 
cannot divide further and go into senescence. Chromosomal instability, cell senescence and 
apoptosis can not only be induced by critically short telomeres but also by disruption in 
telomeric protein complex which is responsible for the loop structure at the chromosome 
ends (Blackburn, 2000; Bryan & Cech, 1999; Collins, 2006; Cong et al., 2002; Feng et al., 1995; 
Greider &Blackburn, 1989; Morin, 1997; Shay & Wright, 2005; Wong et al., 2010; Zakian, 
1995). 
Researches have shown that telomerase is reactivated in most tumour cells. These cells, 
which have been immortalized, need telomerase activity for ensuring the telomere length 
required for genetic stability and unlimited proliferative ability. Telomerase reactivation is 
not sufficient in order to transform a normal cell into a carcinogenic cell, but it is necessary 
for the cells to preserve effective telomere lengths for providing the cells with unlimited 
growth capacity and being immortal. Studies show that there is no telomerase activity in 
benign tumours and that these tumour cells return to early stages as their telomeres get 
shorter. High telomerase activity is observed in more invasive metastatic tumours. For this 
reason, the studies conducted recently bring telomerase to the forefront as a target for 
development of diagnostic, prognostic and therapeutic mechanisms of cancer or even as a 
potential biomarker (Chatziantoniou, 2001; Hiyama & Hiyama, 2002; Kim, 1997; Lichtsteiner 
et al. 1999; Shay &Bacchetti, 1997; Shay & Wright, 2011). 
Another important cellular event associated with telomere and telomerase is apoptosis. 
Cells, which lose their functions in the organism or have some disorders, are destroyed 
through a programmed cell death called apoptosis. Therefore, apoptosis plays an important 
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role in control of normal development in multicellular organisms and regulation of tissue 
homoeostasis. Through apoptosis, which is a physiological mechanism used for elimination 
of immortalized cells, in-vitro development of carcinogenesis may be prevented.  
Apoptosis is characterized by typical morphological changes that cover many factors which 
are responsible for DNA fragmentation and protein cleavage. It occurs mainly through 
pathways activated by extrinsic and intrinsic factors. Extrinsic pathway is induced by 
activation of Tumour Necrosis Factor (TNF) or Fas receptor in target cell membrane. TNF is 
released from macrophage sand initiates cell death. Fas ligand is cell surface protein and 
causes death of cells such as infected cells and tumor cells. Activated TNF and Fas receptors 
compose complex (DISC) with adapter proteins such as TNF receptor associated death 
domain (TRADD) and Fas associated death domain (FADD).  DISC activates caspases 
(cysteine-aspartic-acid-proteases). Caspases are members of cystein protease family and 
they are synthesized as an inactive zimogene. Caspases are activated via proteolytic 
cleavage. In this pathway, caspase-8 is activated. While caspase-8 activates caspase-3, it also 
directly affects some proapoptotic proteins such as BID. Caspases generally serve as initiator 
(caspase 2, 8, 9, 10) and effector (caspase 3, 6, 7) in the apoptotic process. Intrinsic pathway is 
activated by growth factor deprivation, DNA damage, and other stress stimuli. Activated 
intrinsic pathway is interacted with apoptotic proteins. Bcl-2 family members consist of 
proapoptotic or antiapoptotic bcl-2 proteins. Among the members of this family, proteins 
such as Bcl-2, Bcl-XL and Mcl-1 inhibit apoptosis, while proteins such as Bax, Bad, Bid, Bak, 
Bim, PUMA, NOXA stimulate apoptosis. These molecules cause to releasing cytochrom c by 
creating pores. Cytochrom c is localized in intermembrane space of mitochondria. 
Distruption of the outher mitochondrial membrane leads to releasing of endonuclease G, 
Smac/DIABLO, Omi/HtrA2, Apoptosis Inducing Factor (AIF) and cytochrom c into 
cytoplasm. Additionally, proapoptotic proteins such as Bid, Bim, Bad, inhibit Bcl-2 and 
activate Bax/Bak heterodimer. Together with cytochrom c, Apaf-1 and dATP compose the 
apoptosome. The apoptosome cleaves procaspase-9 into caspase-9. Similarly caspase-8 and 
caspase-9 activate caspase-3. Activated caspase-3 causes DNA fragmentation and apoptosis 
by death substrates such as poly (ADP-ribose) polymerase (PARP), Caspase Activated 
DNase (CAD)/Inhibitor of Caspase Activated DNase (ICAD) (Bradshaw et al., 2003; Cain et 
al., 2002; Cory & Adams, 2002; Debatin et al., 2004; Green & Kroemer, 1998; Holdenrieder et 
al., 2004; Kaufmann & Earnshaw, 2000; Kerr, et al., 1972; Letai, 2008; Nuñez et al., 1998; 
Parone et al., 2002; Turgut Cosan & Soyocak, 2012; Wyllie, 1992, Wong, 2011). Proteins 
related with apoptosis in signal pathways and their functions are summarized in Figure 1 
and Table 2.  
Telomere dysfunction induces two types of cellular response. These cellular responses are 
cellular senescence and apoptosis. The researches carried out with regard to the relationship 
among telomere, telomerase and apoptosis report that apoptosis may be induced through 
different mechanisms by weakening telomere/telomerase activity in cancer cells. In one of 
these mechanisms, inhibition of telomerase in cancer cells can result in shortening of 
telomere length and subsequently induce apoptosis. In another telomere/telomerase and 
apoptosis relationship, inhibition of telomerase can result in apoptosis by causing telomere 
uncapping. If telomerase is positive, the tumor grows due to survival signals and long 
telomeres. If telomerase is negative, telomeres are short due to progressive telomere loss. In 
the telomerase negativity stage, if telomerase becomes positive then tumor regrowth is 
initiated. If telomerase is still negative then subsequently telomere fusions, p53 activation,  
Inhibiting Telomerase Activity and Inducing Apoptosis  




Fig. 1. Proteins related to apoptosis in signal pathways and their functions. 
Apoptotic Proteins Functions References 
Caspase Family 
(e.g. Caspase 3,6,7,2,8,9,10) 
Caspases are members of a 
cystein protease family and are 
synthesized in the form of 
inactive zymogens activated by 
proteolytic cleavage. The 
intracellular transmission of the 
apoptotic signal is regulated by 
caspase family. 
Bradshaw et al. (2003) 
Holdenrieder et al. (2004) 
Wong (2011) 
Bcl-2 Family 
(e.g. Bcl-2,Bcl-XL,Mcl-1,Bax, Bad, 
Bid, Bak,Bcl-XS, NOXA, PUMA) 
Bcl-2 family proteins can target 
the mitochondria and regulated 
membrane permabilization. 
Bradshaw et al. (2003) 
Debatin et al. (2004)  
Wong (2011) 
p53 
P53 is a tumor-supressor and 
transcription factor. It is a critical 
regulator in many cellular 
prosesses including cell signal 
transduction, cellular response to 
DNA-damage, genomic stability, 
cell cycle control, and apoptosis. 
Aggarwal & Shishodia (2006) 
 
IAPs 
(Inhibitor of Apoptosis Proteins) 
(e.g. Survivin, IXAP) 
IAPs block activity of caspases 
and may target active caspases 
for degradation.  
Bradshaw et al. (2003) 
Debatin  et al. (2004) 
Kroemer et al. (2007) 
Wong (2011) 
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Apoptotic Proteins Functions References 
AIF 
(Apoptosis Inducing Factor) 
AIF induce apoptosis by causing 
DNA fragmentation and 
chromatin condensation. 




Endo G is a mitochondrion-
specific enzyme and it cleaves 
chromatin DNA into 
nucleosomal fragments. 




activator of caspase/ 
direct IAP binding protein with 
low pI) 
Smac/DIABLO is proapoptotic 
mitochondrial protein. It 
promotes caspase activation by 
binding to IAPs that 
subsequently leads to disruption 
in the interaction of IAPs with 
caspases. 






high temperature requirement 
protein A2) 
Omi/HtrA2 is proapoptotic 
mitochondrial protein. It 
promotes caspase activation by 
binding to IAPs that 
subsequently leads to disruption 
in the interaction of IAPs with 
caspases. 
Kroemer et al. (2007) 
Wong (2011) 
CAD / ICAD 
(Caspase Activated DNase/ 
Inhibitor of Caspase Activated 
DNase) 
CAD cleaves chromosomal DNA 
in a caspase-dependent manner 
during apoptosis. When 
apoptosis is activated ICAD is 
cleaved by executor caspases.  
Nagata (2000) 
Omata et al. (2008) 
 
Table 2. Some proteins involved in apoptosis. 
cell arrest or/and apoptosis occur (Akiyama et al., 2002; Cong & Shay, 2008; Gao & Chen, 
2007; Herbert et al., 1999; Lechel et al., 2005; Mattson et al., 2001; Mondello & Scovassi, 2004; 
Multani et al., 2000; Shay & Wright, 2006; Yuan & Mei, 2002; Zhang et al., 1999). 
Signals leading to apoptosis in telomerase inhibited cells are still not fully understood. Upon 
loss of chromosome end protection function, uncapped telomeres are recognized by 
specialized DNA damage sensors. Uncapped telomeres activate signaling cascades 
involving the protein kinases member of PI3-kinase like (PIKK) family include Ataxia 
Telangiectasia Mutated (ATM), Ataxia Telangiectasia and Rad3 related protein (ATR), and 
DNA-PK. ATM and ATR are protein kinases which regulates cellular response to DNA 
breaks. ATM and ATR phosphorylate several proteins in response to DNA damage. These 
responses include the activation of cell cycle checkpoints, DNA repair and apoptosis. Two 
important phosphorylation substrates of ATM and ATR are cell cycle checkpoint kinase 1 
(Chk1) and cell cycle checkpoint kinase 2 (Chk2). These proteins act by regulating cyclin 
dependent kinases (CDK) inhibitory effectors such as Cdc25a, Wee1 or p53. Chk1 and Chk2 
are the central activators of p53 in response to DNA damage. The p53 transcription factor 
stops the cell cycle in case of an abnormal situation in the cell. PARP is connected to the 
broken DNA chain and adds poly (ADP-ribose) to nuclear proteins such as histone. Caspase 
3 is connected to PARP in apoptosis and prevents repair of damaged DNA. Apoptosis, 
which is a highly-organized physiological mechanism, plays an essential role as a 
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mechanism that is protective against carcinogenesis through elimination of genetically-
damaged cells (Aggarwal & Shishodia, 2006; Ben-Porath & Weinberg, 2005; d'Adda di 
Fagagna, 2003; Ljungman, 2009; Lopez-Contreras & Fernandez-Capetillo, 2012; Mondello & 
Scovassi, 2004; Smith et al., 2003; Takai et al., 2003; Karlseder et al., 1999; Kurz& Lees-Miller, 
2004; Roos & Kaina, 2006; von Zglinicki et al. 2005).  
Various studies report that some compounds, in particular, natural compounds, inhibit 
telomerase activity and induce apoptosis. For this reason, it is of great importance for 
studies to focus on potentials of natural compounds to inhibit telomerase activation and 
induce apoptosis of tumour cells without giving harm to normal cells. The researches 
conducted generally emphasize on two beneficial effects of natural compounds. These 
beneficial effects of natural compounds are potential anti-carcinogenic effects and few or 
milder side effects in normal cells. Some researches showed that resveratrol, which is the 
most investigated among the compounds we will discuss in this chapter, does not induce 
apoptosis in normal cells. In vivo studies carried out with resveratrol clearly demonstrate 
that it is safe in pharmacological terms and it can be used in treatment of cancer. It was also 
revealed that similar to resveratrol, quercetin has minimized side effects on normal cells and 
therefore it is safe to be used in certain doses. On the other hand, the number of studies 
conducted with tannic acid is very limited. Through further studies to be conducted in the 
following years, behaviours of tannic acid on normal cells can be identified (Aalinkeel et al., 
2008; Aggarwal et al., 2004; Fulda& Debatin, 2006; Granado-Serrano et al., 2006;  Psahoulia  
et al., 2007; She et al., 2003; Shu et al., 2011).  
Determination of a relation between telomerase enzyme/apoptosis and natural compounds 
is important as it suggests that undesired effects of the compounds used in the current 
treatment methods can be eliminated. In this review, an emphasis will be placed on 
telomerase regulation – which is quite important for formation of human cancers –and on 
mechanisms that result in apoptosis and impacts and inter-relations of resveratrol, quercetin 
























Fig. 2. Name of phenolic compounds and chemical formules. 
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2. Effects of polyphenols on telomerase activity and apoptosis in cancer cells 
It is a known fact that cancer cells, which have the ability to reproduce infinitely, cannot 
resist some of the compounds in the food we consume daily. One of these compounds, 
polyphenols, bears anti-carcinogenic properties. These polyphenols are contained in fruits, 
vegetables, seeds and drinks and are classified as stilbenes, flavonoids, tannins, phenolic 
acids and their analogues, lignans and others depending on their chemical structures 
(Huang et al., 2010a; Ramos, 2008).  
These polyphenolic compounds that taken by diet show their effects through similar or 
different molecules in the cells. As a result of these effects, they may lead to inhibition of 
telomerase activity while inducing apoptosis in cancer cells (Avci et al., 2011; Fuggetta et al., 
2006; Lanzilli et al., 2006; Sadava et al., 2007; Turgut Cosan et al., 2011; Wang et al., 2007). 
The studies that underline the relationship between these two incidents are limited. In this 
chapter, we aim to draw attention to the effects of resveratrol, tannic acid and quercetin, 
which are among important polyphenols, on telomerase activity and apoptosis in multiple 
breast and colon cancer cases and their probable relationships. The effects on telomerase 
activity and apoptosis of these compounds are summarized in Figure 3.  
 
Fig. 3. Interaction of telomerase activity and apoptosis in cancer cells. 
2.1 Resveratrol  
Resveratrol (3,5,4’ trihydroxystilbene) is a phytoalexin phenolic compound. Resveratrol is 
contained in the root of Polygonumcuspidatum plant and peanut as well as small soft fruits 
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such as grape, mulberry, strawberry, blackberry and drinks made of these. Resveratrol 
chelates copper, is neuroprotective, has oestrogen regulation activity, inhibits lipid 
peroxidation, causes alteration of eicosanoid, and inhibits platelet aggregation. It has anti-
oxidant, anti-carcinogenic, anti-inflammatory, anti-mutagen, anti-proliferative, anti-viral, 
anti-bacterial activities, and cardioprotective and vasorelaxing activities (Aziz et al., 2003; 
Corre et al., 2005; Gusman et al., 2001; Ignatowicz &Baer-Dubowska, 2001; Pervaiz, 2003).  
2.1.1 Resveratrol, telomerase and apoptosis 
Studies have been carried out to investigate the effect of resveratrol on telomerase enzyme 
and apoptosis in cancer cells.  In one of these researches, Del Bufalo et al. (2005) also stated 
that hTERT plays an important role in direct or indirect control of cell survival upon 
regulation of genes that function in apoptosis. hTERT appears to affect apoptosis by directly 
intervening in early phases of upstream of intrinsic apoptotic pathway.  
Fuggetta et al. (2006) indicated that tumour growth and progression can be prevented 
through resveratrol. These authors examined the effect of resveratrol on telomerase activity 
and growth in human colon cancer cell lines HT-29 and WiDr. Resveratrol showed a dose-
dependent inhibiting effect on cell proliferation in both cell lines. In addition, this 
compound down-regulated telomerase activity in higher concentrations. It was stated in this 
study that in various epithelial cancers including colon cancer, a close relationship existed 
between hTERT mRNA expression and high telomerase activity. hTERT inhibition results in 
telomere loss, which leads to apoptosis and limits tumour cells growth. In this case, 
telomeres of these cells reached a critically short length.  
A study conducted by Lanzilli et al. (2006) investigated the potential role of resveratrol as 
chemoprevention/chemotherapy for breast cancer. They indicated that resveratrol showed 
direct inhibitive impact on cell proliferation. They demonstrated that resveratrol induced 
apoptosis in MCF-7 breast cancer cells depending on time and concentration. Furthermore, 
they indicated that it reduced telomerase activity, inhibited growth in connection with this 
and that it did so through induction of apoptosis and S-phase arrest. According to 
hypothesis of this study, resveratrol directly down-regulates telomerase activity and 
indirectly affects the signal pathways including apoptosis and cell cycle control. 
Various studies demonstrate that the catalytic subunit hTERT can activate telomerase 
activity as a result of its post translational phosphorylation and nuclear translocation (Liu et 
al., 2001; Seimiya et al. 2000). In addition, in a research they conducted on colon cancers, 
Wang et al. (2010) reported that resveratrol reduced promoter activity of hTERT and, in this 
way, prevented proliferation of cancer cells by inhibiting hTERT expression.  
In their studies, Turgut Cosan et al. (2011) examined the impacts of resveratrol on 
telomerase activity and apoptosis in MCF-7 human breast and CaCo-2 human colon cancer 
cell lines. They found that resveratrol was more effective in reducing cell viability of MCF-7 
cells compared to CaCo-2 cells. Resveratrol also had a negative regulatory effect on 
telomerase activity. DNA fragmentation, which is seen at all times and concentrations, 
shows that apoptosis occurs in cells treated with resveratrol. These impacts do not entirely 
depend on time and concentration. The study supports this impact of resveratrol with the 
alterations in cell count and cell viability.  
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More studies are needed to further increase our knowledge of resveratrol induced 
telomerase-apoptosis interactions. In this way, whether resveratrol induces any link 
between telomerase and apoptosis and, if it does, which molecular mechanisms are utilized 
by it can be revealed clearly. 
2.2 Tannic acid 
Tannins are polyphenolic compounds with molecular weight of 500-3000 Dalton. Tannins are 
divided into two classes as hydrolyzed and condensed. Tannic acid, which is hydrolyzed 
tannin, is contained in tea, coffee, grapes, red wine, beans, and nuts such as hazelnut and most 
fruits and vegetables. Apart from their anti-angiogenic, anti-bacterial, anti-carcinogenic, anti-
oxidant, anti-mutagenic, anti-microbial, anti-allergic and anti-proliferative activities, tannic 
acids have such biological activities as chemopreventive effects (Chen et al., 2003; Chung et al., 
1998; Khan& Hadi, 1998; Khan et al., 2000; Naus et al., 2007; Taffetani et al., 2005).  
2.2.1 Tannic acid, telomerase and apoptosis 
Various studies are available in which cancer chemopreventive activity of tannic acid is 
presented (Chen et al., 2003; Chung et al., 1998; Gali-Muhtasib et al., 2000; Kazi et al., 2003; 
Khan & Hadi, 1998; Koide et al., 1999; Marienfeld et al., 2003; Nam et al., 2001a; Nepka et al., 
1999a; Nepka et al., 1999b). Gali-Muhtasib et al., 2000, demonstrated that tannic acid can 
suppress promotion of skin tumour induced by ultraviolet-B radiation in an animal study. 
Nepka et al., 1999b, reported that dietary consumption of low-dose tannic acid strongly 
showed dose-dependent chemopreventative activity against spontaneous liver tumour 
development in C3H male rats. It was revealed by Koideet al., 1999 that tannic acid 
increased survival rate of Balb/c rats carrying syngeneic tumours. In other researches, it was 
demonstrated that ester bond-containing tea polyphenols of tannic acid inhibit potently and 
specifically chymotrypsin-like activity of proteasome in vitro and in vivo  (Marienfeld et al., 
2003; Nam et al., 2001a; Nam et al., 2001b). Nam et al., 2001a, and Kazi et al., 2003, reported 
that anti-cancer impact of tannic acid arose from induction of apoptosis as well as inhibition 
of proteasomal activity. Other researches executed also showed that tannic acid could 
induce apoptosis (Labieniec et al., 2006; Pan et al., 1999; Romero et al., 2002; Sakagami et al., 
2000; Wang et al.; 2000; Yang et al., 2000). 
However, the impacts of tannic acid on telomerase enzyme activity and apoptosis have not 
been addressed except in the research we executed (Turgut Cosan et al. 2011). We 
investigated the impact of tannic acid in breast and colon adenocarcinoma cells and found 
that cell viability and cell count dropped dramatically when cells were treated with tannic 
acid. Tannic acid reduced telomerase activity in all concentrations independent of time and 
dose. On the other hand, DNA fragmentation, which is seen at all times and concentrations, 
shows that tannic acid induces apoptosis in breast and colon cancer cells. Thus, it can be 
asserted that tannic acid has a suppression effect on telomerase activity and inducing effect 
on apoptosis. We also found that telomerase activity is lower in breast cancer cells than in 
colon cancer cells. In line with this conclusion, it can be mentioned that tannic acid has 
different effects in different cell lines.  
In various studies, the impacts of (-) epigallocatechin-3-gallate (EGCG), a tea polyphenol 
like tannic acid, on telomerase enzyme activity and apoptosis in cancer cells were examined. 
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In 2007, Sadava et al. examined DNA fragmentation and telomerase activity in cancer cells 
treated with EGCG, similarly to studies by Turgut Cosan D et al. 2011. These studies were 
performed on drug resistant and drug sensitive lung cells (H69VP, H69). They reported that 
EGCG and green tea inhibit telomerase activity in cancer cells and these cells show molecular 
characteristics of apoptosis. These results imply that EGCG may have simultaneous impact on 
both apoptosis and telomerase activity in small cell lung carcinomas. There are some studies 
reporting that EGCG, abundant in green tea such as tannins, has growth inhibitory effect on 
cancer cells but not on normal cells (Bode& Dong, 2009; Chung et al., 2003). 
Another study demonstrated that, following long term treatment of non-toxic low dose 
EGCG, carcinoma cells aged, telomere shortening was induced and telomerase inhibition 
occured in vitro (Naasani et al., 2003). In another study conducted on lung, oral cavity, 
thyroid and liver carcinoma cells, it was reported that low cytotoxic dose EGCG and (-) 
epigallocatechin (EGC) suppressed hTERT expression on reporter system and hTERT 
mRNA level (Lin et al., 2006). On the other hand, it was demonstrated in this study that tea 
polyphenols can materialize inhibition of cancer cells in many ways.  
Understanding the effect of tea polyphenols like tannic acid on molecular mechanism of 
malignancies bears importance in order for these polyphenols, which seem to be 
advantageous for treatment and prevention, to become useable.  
2.3 Quercetin 
Quercetin (3,5,7,3’,4’-pentahidroksiflavon) is a flavonoid which is contained very commonly 
in fruits and vegetables including onion, tomato, broccoli, red wine, green tea, apples, 
grapes, berries, cherries, and citrus fruits. Apart from anti-cancer, anti-allergic, anti-
inflammatory, anti-oxidant, anti-tumour, anti-viral and anti-microbial properties, quercetin 
has many beneficial impacts on human health such as inhibition of lipid peroxidation, anti-
platelet, anti-hypertensive, anti-cataract and anti-neurodegenerative effects (Aherne 
&O’Brien, 2002; Bischoff, 2008; Middleton et al., 2000; Perez-Vizcaino, 2009).  
2.3.1 Quercetin, telomerase and apoptosis 
Biologically useful impacts of quercetin are revealed by many studies. One of the objectives 
of these studies is to be able to understand the molecular mechanisms of these useful 
impacts in cancer and the interactions among them. Various researches demonstrate that 
this polyphenol can play a role in cancer treatment and prevention by inhibiting telomerase 
activity and inducing apoptosis and cell cycle arrest.  
In a 2000 study, Nakayama et al. stated that growth and telomerase activity was inhibited as 
a result of treatment with estrogen receptor beta ligands (such as quercetin and tamoxifen) 
in colon cancer cells. In another study, Naasani et al. (2003) also reported that quercetin has 
the ability to inhibit telomerase activity. On the other hand, Hu et al. (2004) indicated that 
quercetin administered to these cells did not inhibit hTERT mRNA in malignant melanoma 
cells. In literature, apart from studies reporting that quercetin has an effect on telomerase 
activity, information on its ineffectiveness is also available.  
With respect to the researches on the impact of quercetin on apoptosis, Choi et al. (2001) 
reported that quercetin induces growth inhibition with at least two different mechanisms in 
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MCF-7 cell lines. One of these is the inhibition of cell cycle progression through a transient 
M phase accumulation and subsequent G2 arrest while the other one is induction of 
apoptosis. Kang & Liang (1997) administered quercetin to human promyelocytic leukemia 
cells (HL-60) and observed its anti-tumour activity. They emphasizes that one of the 
mechanisms used by quercetin is its inducing of apoptosis. Kuo et al. (2004) showed that 
quercetin induces apoptosis and cytotoxic effects in human lung cancer cell lines in a dose 
dependant manner. When quercetin is administered to the cells at higher doses, cell 
proliferation was almost completely inhibited. Lee et al. (2006) demonstrated that quercetin 
administered to human leukemic monocyte lymphoma cells increased DNA fragmentation 
in a dose dependent manner and induced apoptosis by caspase activation and G2/M phase 
arrest. In a different study, Kou (1996) observed that quercetin can induce apoptosis in colon 
cancer cells in a dose dependant manner. On the other hand, Gibellini et al. (2011) 
emphasized that in various types of cancer cells; quercetin can arrest the cells at different 
cycles and block their growth. Therefore, they exhibit pro-apoptotic feature. Furthermore, 
this article touches on quercetin showing anti-proliferative and pro-apoptotic effects as well 
as anti-carcinogenic properties. Therefore, it was pointed out that studies need be conducted 
on more complex and sophisticated animal models in order to understand mechanisms of 
chemopreventive and chemotherapeutic effects of quercetin. Tang et al. (2010) stated that 
quercetin shows many properties in cancer cells such as death receptor 5 (DR5) 
upregulation, p53 activation, cell cycle arrest and caspase-mediated apoptosis. It was 
underlined in this study that while quercetin down regulates expression of heat shock 
protein 90 (Hsp90) in prostate cancer cells and induces growth inhibition and apoptosis; it 
has no measurable effect on normal prostate epithelial cells. Unlike the unclear statements 
about the impact of quercetin on telomerase activity, the effect of quercetin on apoptosis is 
obvious. Almost all studies prove that quercetin induces apoptosis in cancer cells.   
Although there are limited number of studies which examine both telomerase activity and 
apoptosis together, in a recent research conducted by Avci et al. in 2011, the impacts of 
quercetin on telomerase activity, apoptosis-mediated cell death, and cell reproduction in 
leukemic cells were addressed. In CCRF-CEM human T-cell acute lymphoblastic leukemia, 
HL-60 human acute promyelocytic leukemia, and K-562 human chronicmyeloid leukemia 
cells, quercetin suppresses telomerase activity and induces apoptosis. It was therefore stated 
that quercetin is a potential therapeutic agent for treatment of leukaemia. In 2007, Wang et 
al. demonstrated that quercetin inhibited growth in lung cancer cell line, induced apoptosis 
and down regulated hTERT expression in a dose dependant manner. Wei et al. (2007) 
reported that quercetin has a suppressing effect on growth in gastric cancer cells SGC-7901. 
They found that quercetin realized anti-cancer activity by suppressing telomerase activity 
and inducing apoptosis. Cheng et al. (1998) emphasized that treatment of nasophargeal 
carcinoma cells (NPC) with cisplatin or quercetin ensured activation of mitotic arrest and 
apoptotic pathways. They indicated that apoptosis of NPC cells can be induced through 
induction of mitotic arrest. Furthermore, it was emphasized that it has still not been clarified 
whether there is a correlation between apoptosis and telomerase activity. In another study 
conducted by Ak et al. (2011), it was reported that quercetin induce apoptosis in breast 
cancer cells but did not reduce telomerase activity. In a 2011 study, Turgut Cosan et al. 
stated that quercetin is effective on apoptosis in CaCo-2 human colon cancer cell lines. In 
this study, it was found that quercetin has no effect on cell viability and cell count, and that 
it has very little effect on telomerase activity. On the other hand, when the level of DNA 
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fragmentation was examined, quercetin is reported as effective. In this case, a full 
correlation is not observed between apoptosis and telomerase activity. When all these 
studies are taken into consideration, it can be provided that quercetin is more effective on 
apoptosis and mainly shows its anti-carcinogenic effect via this mechanism.   
After giving all the above information, we cannot proceed without mentioning the fact that 
natural compounds have separate impacts on cancer cells and they can have increased impact 
when combined. Zamin et al. (2009) found that quercetin and resveratrol combination forms a 
very strong synergy in inducing senescence-like growth arrest in glioblastoma cells. The same 
study revealed that apoptosis induction does not occur through combinations made at low 
concentrations but that higher concentration combinations are effective. Kuhar et al. (2007) 
administered curcumin and quercetin together with cisplatin to human laryngeal carcinoma 
(Hep-2) cells. It was concluded that both compounds induce apoptosis through mitochondrial 
pathway and their adverse effects can be minimized. Identification of therapeutic 
concentrations in anti-tumoural activity bears great importance in emergence of these effects.  
It is beyond doubt that further research is needed where all important molecules in anti-
cancer mechanisms are addressed together in order to understand better the mechanism of 
impacts of quercetin on telomerase enzyme activity and apoptosis.  
3. Inhibition of telomerase and induction of apoptosis by other polyphenols 
Dietary polyphenols are compounds contained in fruits, vegetables and seeds and classified 
according to their chemical and structural differences. The idea that these polyphenols, 
which approximately has 8,000 varieties, can play a role in preventing cancer has recently 
created the necessity to illuminate the mechanisms of their action in cancer cells (Han et al. 
2007; Ramos, 2007; Saunders & Wallace, 2010).  
In addition to some polyphenols focused on here, relationships of telomerase inhibition and 
apoptosis induction of other polyphenols with cancer are shown in Table 3.  
 
Products Cells Mechanisms of action Reference 
Curcumin 
MCF-10A  
Human mammary epithelial cells 
MCF-7  
Human breast  cancer cells  
Inhibits telomerase activity 
by down-regulating hTERT 
expression. 
Ramachandran 
et al. (2002) 
HL-60  
Human acute myeloblastic 
leukemia cells  
Induced apoptosis.
Inhibition of telomerase 
activity in a dose dependent 
manner. 
Mukherjee et al. 
(2007) 
K562  
Human chronic myelogenous 
leukaemia cells 
Induced apoptosis. 





Human hepatocellular liver 
carcinoma cells 
Inhibited cell growth. 
Induce apoptosis. 
Inhibit telomerase activity. 




Human gastric carcinoma cells 
Inhibited telomerase activity.
Reduced telomere length. 
Arrested tumor cell cycle in 
G2/M phase. 
Zhang et al. 
(2002) 
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Products Cells Mechanisms of action Reference 
Allicin 
SGC-7901  
Human gastric cancer cells 
Induce apoptosis. 
Inhibit telomerase activity. 
Sun & Wang 
(2003). 
Diterpenoids 
    -Xerophilusin B 
    -Macrocalin B 
    -Eeriocalyxin B 
 
K562  
Human chronic myelogenous 
leukaemia cells  
HL-60  
Human acute myeloblastic 
leukemia cells A549  
Human lung carcinoma cells 
HCT  
Human colorectal carcinoma cells 
MKN  
Human gastric adenocarcinoma 
cells  
CA  
Human live carcinoma cells 
Inhibit the proliferation and 
the telomerase activity. 
Yang et al. (2009) 
Salvicine 
HL-60  
Human acute myeloblastic 
leukemia cells 
Induce apoptosis. 
Inhibit telomerase activity. 
Liu et al. (2002) 
( Z )-Stellettic acid 
U937  
Human leukemic cells 
Dose-dependent growth 
inhibition.  
Induce apoptosis was 
associated with an increase 
in Bcl-2 family expression, 
activation of caspases and 
down regulation of IAPs 
family members. 
Down regulation of hTERT 
expression . 





Human alveolar epithelial 
carcinoma cells 
MCF-7  
Human breast  cancer cells  
HeLa  
Human cervical cancer cells 
EL-1  
Humanmonocyte cells 
Induces apoptosis by Bcl-2 
suppression and activation 
of caspases. 
Decrease in the activity of 
telomerase. 





Human hepatocarcinoma cells 
(p53-positive)  
Hep 3B  
Human hepatocarcinoma cells 
(p53-negative) 
Apoptosis by down 
regulation of Bcl-2 and by up
regulation of Bax 
functioning upstream of 
caspase-3 in both cell lines.  
Down regulation of 
telomerase activity.  
 




Induction of apoptotic cell 
death through activation of 
caspase. 
Inhibition of telomerase 
activity through 
Choi et al. (2004) 
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Products Cells Mechanisms of action Reference 
transcriptional down  
regulation of hTERT.  
Inhibition of telomerase 
activity and induction of 
apoptosis resulted from 
dephosphorylation of Akt in 




Human cervical cancer cells 
 
Inhibited the cell growth and 
cell cycle. 
Induce apoptosis. 
Inhibit telomerase activity.  




Human leukemic cells 
Induction of apoptosis.  
Inhibit telomerase activity. 
Cell growth inhibition. 





Human lung carcinoma cells 
NSCLC  
Human non-small cell lung cancer
cells 
Cell growth inhibition.  
Apoptosis induction 
(associated with the 
induction of Fas, catalytic 
activation of caspase-8, and 
Bid cleavage). 
Dose-dependent inhibition 
of telomerase activity via 
down regulation of human 
telomerase reverse 
transcriptase (hTERT), c-myc
and Sp1 expression 




Human acute myeloblastic 
leukemia cells 
Growth inhibition.  
Induction of Bax/Bcl-2 
apoptosis.  
Telomerase inhibition 
through suppression of c-
myc. 




Human leukemic cells  
THP-1  
Human acute monocytic 
leukemia cells 
K562  
Human chronic myelogenous 
leukaemia cells 
Induces apoptosis.  
Represses telomerase 
activity.  
Kim et al. 
(2008b) 
Table 3. Mechanisms of action of natural products. 
4. Conclusion 
In this chapter, recent research results of the impacts of natural compounds on telomerase 
inhibition and apoptosis induction in cancer cells are summarized. Researches suggest that 
polyphenols alter telomerase activity and induce apoptosis by affecting proteins that 
function in various signal pathways. We showed that the possible relationship between the 
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impacts of natural compounds on telomerase inhibition and apoptosis induction. Some 
studies suggest that telomerase activity is connected to regulation of apoptosis in 
physiological and pathological terms. However, it is also a fact that every compound cannot 
directly affect both of the mechanisms simultaneously. More detailed knowledge about 
polyphenols and the mechanism responsible for telomerase inhibition and apoptosis 
induction and the true effectiveness of polyphenols would help to determine whether 
polyphenols is a potential chemopreventive and chemotherapeutic reagent for treatment of 
cancer.  
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